Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been clinically diagnosed with a specific type of uterine (endometrial) cancer called endometrioid-type endometrial cancer, and who have tissue samples available.
- People who have had surgery at INCan (the National Cancer Institute in Mexico).
Who may not be able to join:
- People whose tissue samples are from a type of uterine cancer other than endometrioid-type.
- People whose samples come from a diagnosis involving two separate primary cancers at the same time, including certain breast, skin, or cervical cancers (confirm with trial site).
- People who have a history of any cancer diagnosed less than 5 years ago, unless there is no remaining sign of that cancer.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David F Cantu-de-León, PhD, The Principal Investigator
Phone: +52-55-5628-0400
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
sequence the exome; Determine POLE mutations; Determine microsatellite instability; Validation
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.